Successful Outcome of Hyperhemolysis in Sickle Cell Disease following Multiple Lines of Treatment: The Role of Complement Inhibition-Reference-Cited by-同舟云学术

Successful Outcome of Hyperhemolysis in Sickle Cell Disease following Multiple Lines of Treatment: The Role of Complement Inhibition

Published:2018-11-02 Issue:5-6 Volume:42 Page:339-341
ISSN:0363-0269
Container-title:Hemoglobin
language:en
Short-container-title:Hemoglobin

Author:

Vlachaki Efthymia¹,Gavriilaki Eleni²,Kafantari Katerina¹,Adamidou Despoina³,Tsitsikas Dimitris⁴,Chasapopoulou Eleni⁵,Anagnostopoulos Achilles²,Tsapas Apostolos¹

Affiliation:

1. Adult Thalassaemia Unit, 2nd Department of Internal Medicine, Aristotle University of Thessaloniki, Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece;

2. Haematology Department, Bone Marrow Transplantation Unit, G. Papanicolaou Hospital, Thessaloniki, Greece;

3. Blood Bank, Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece;

4. Haemoglobinopathy Service, Homerton University Hospital National Health Service Foundation Trust, London, UK;

5. Blood Bank, AHEPA Hospital, Thessaloniki, Greece

Publisher

Informa UK Limited

Subject

Biochemistry (medical),Clinical Biochemistry,Genetics (clinical),Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03630269.2018.1540353

Reference12 articles.

1. Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience

2. Delayed hemolytic transfusion reaction in children with sickle cell disease

3. Catastrophic Delayed Hemolytic Transfusion Reaction in a Patient With Sickle Cell Disease Without Alloantibodies: Case Report and Review of Literature

4. Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab

5. Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eculizumab for management of hyperhemolysis syndrome in pediatric patients with sickle cell disease: A single‐center case series;Pediatric Blood & Cancer;2024-06-05

2. Genetics and Epigenetics in Acquired Hemophilia A: From Bench to Bedside;Current Issues in Molecular Biology;2024-05-23

3. What is the role of complement in bystander hemolysis? Old concept, new insights;Expert Review of Hematology;2024-05-03

4. Alloimmunization and hyperhemolysis in sickle cell disease;Hematology;2023-12-08

5. “Don’t Add Fuel to the Fire”– Hyperhemolysis Syndrome in a Pregnant Woman with Compound Sickle Cell Disease/β0-Thalassemia: Case Report and Review of the Literature;Acta Haematologica;2023-10-13